To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Unknown status
Condition(s):Ovarian Cancer RecurrentLast Updated:November 20, 2019Completed
Condition(s):Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer Stage IV; Pancreatic Cancer Non-resectable; Pancreatic Cancer MetastaticLast Updated:April 12, 2023Withdrawn
Condition(s):Metastatic Soft Tissue Sarcoma; Advanced Soft Tissue SarcomaLast Updated:December 21, 2023Recruiting
Condition(s):Advanced Malignant TumorsLast Updated:April 29, 2022Recruiting
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:November 18, 2023Recruiting
Condition(s):Soft Tissue SarcomaLast Updated:June 2, 2016Completed
Condition(s):Hepato Cellular CarcinomaLast Updated:July 27, 2020Completed
Condition(s):Cutaneous Squamous Cell Carcinoma; Skin Cancers – Squamous Cell CarcinomaLast Updated:February 20, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:July 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.